Wednesday, November 12th
The Bridge Building - 2 Victory Ave #100, Nashville, Tennessee

Hemant Taneja is the CEO of General Catalyst, and a founder, investor, and author of four books, including The Transformation Principles. His worldview centers on strengthening global resilience through applied AI and partnerships that modernize critical systems. Hemant is an early investor in the leading technology companies of our time including Anduril, Anthropic, Applied Intuition, GitLab (NASDAQ: GTLB), Grammarly, Gusto, Ro, Samsara (NYSE: IOT), Snap (NYSE: SNAP), and Stripe. He is also deeply involved in transforming the US healthcare system, having founded companies like Commure, Hippocratic, Transcarent, Livongo (Sold to Teladoc for $18.5B) and General Catalyst's Health Assurance Transformation Company (HATCo) which helps health systems transform themselves with AI. A global expert on industry transformation, he has led General Catalyst's foray into transforming healthcare, energy, and workforce systems globally. He holds five degrees from MIT.

Dr. Stephen Klasko is a pioneering healthcare innovator bridging traditional academic medicine with generative AI, digital medicine, and entrepreneurship. His transformative career includes serving as dean of two medical colleges, health system CEO, and university president. Recognized as the #2 most influential individual in healthcare by Modern Healthcare, one of the "top 25 most creative people in business" by Fast Company, and "entrepreneur of the year" by Ernst and Young, In his current roles at General Catalyst, Sheba and DocGo, Dr. Klasko consistently drives revolutionary change in healthcare and higher education, positioning him as a visionary leader at the intersection of medicine, technology, and innovation.

Dr. Vikesh Tahiliani  serves as Vice President and Domain Leader for Clinical Documentation  Transformation. In this capacity, he provides clinical leadership focused on  identifying opportunities to alleviate the burdens associated with  documentation. His responsibilities include utilizing advanced technologies,  such as artificial intelligence, to reduce administrative workload for  clinicians, ensuring the production of high-quality documentation, and  leveraging accurate, compliant documentation to drive business value.  Dr. Tahiliani isboard certified in both Internal Medicine and Clinical Informatics. Prior to joining the corporate team, he heldthe positions of Division Director of Hospital Medicine and Division ChiefMedical Information Officer for the MidAmerica Division.

Evan Kramer is an SVP of Innovation & Operational Excellence at Compassus, a nationwide provider of home-based care.  He leads strategic transformation efforts that support patients / clinicians, drive efficiencies, and create value through process improvement and the application of AI and other digital technologies.  In previous experience, Evan was a Principal in Boston Consulting Group’s healthcare and technology practices and, prior to that, worked at Accenture.  He holds an MBA from the McCombs School of Business – University of Texas and undergrad degrees in business and music from the Berklee College of Music.

Dr. Kermit Murray is a board-certified family physician with nearly three decades of clinical experience and a proven record of leadership in value-based primary care transformation. He earned his medical degree from Temple University School of Medicine and has served patients and communities with dedication for 29 years.

Since 2018, Dr. Murray has served as Chief Medical Officer of Carondelet Medical Group in Tucson, Arizona, where he continues to maintain an active clinical practice. In 2019, he was appointed Primary Care Medical Director for Tenet Healthcare’s Arizona market, leading initiatives that enhance quality, access, and efficiency across the network’s primary care practices. Earlier this year, he was elected Co-Chair of Tenet’s National Primary Care Forum, a leadership body composed of physician ambassadors from across the country that collaborates with Tenet administration to advance innovation, policy, and best practices across markets.

Prior to joining Carondelet Medical Group, Dr. Murray was a faculty member at the University of Miami School of Medicine and previously operated a successful solo family practice. His career reflects a commitment to clinical excellence, innovation, and the integration of emerging technologies—including early adoption of AI tools—into the delivery of high-quality, patient-centered care.

Phillip Wood is the Executive Director over Partnerships at Intermountain Ventures with over 15 years of experience in financial and program management. In this role, he oversees piloting and partnership activities between Intermountain Health and target investment companies. During his first year, he rebuilt the Partnerships team, standardized workflows, created process templates, and implemented tools to enhance efficiency. His collaborative efforts with internal stakeholders have strengthened organizational relationships, supported Intermountain Health’s strategic initiatives, and showcased his ability to build cohesive, multi-disciplinary teams.
‍
With a robust background in program management, Phillip previously led program management teams at Accenture Federal on various federal engagements, where he oversaw business operations, developed financial reporting structures, and operated Earned Value Management systems. Holding a BA in Political Science from Utah State University, and an MBA with an emphasis in Finance and Strategy from the University of Maryland Smith School of Business, he brings a strategic mindset and a passion to deliver results to any team he’s a part of.

Louis Potters, MD, FASTRO, FABS, FACR, is an internationally renowned expert in prostate cancer treatment and a pioneer in radiation oncology. He serves as Senior Vice President and Deputy Physician-in-Chief of the Northwell Cancer Institute and chairs its Department of Radiation Medicine. Over his 32-year clinical career, Dr. Potters has treated thousands of prostate cancer patients and advanced the field through clinical innovation, research, and policy leadership. As a key architect of national cancer treatment guidelines and advisor to the U.S. Nuclear Regulatory Commission, he has shaped modern standards for radiation oncology safety and quality. He has also served on the Commission on Cancer executive committee, National Quality Forum panels, and multiple Health and Human Services committees, influencing healthcare quality and policy at the national level.

A senior editor of Practical Radiation Oncology and editorial board member for Oncology and Brachytherapy, Dr. Potters has published more than 200 peer-reviewed papers that have advanced prostate cancer care and quality assurance. His “Smarter Radiation Oncology” program has earned international recognition for elevating standards in patient experience, safety, and outcomes. Under his leadership, Northwell’s Department of Radiation Medicine has become one of the nation’s largest and most innovative programs, uniting clinical excellence, research, and education. A member of Alpha Omega Alpha and a perennial Castle Connolly “Best Doctor” featured in New York Magazine and The New York Times, Dr. Potters continues to drive innovation in personalized, high-quality cancer care.

Dr. Laura Cooley is Editor-in-Chief of the Journal of Patient Experience and Co-Editor of the book Communication Rx: Transforming Healthcare through Relationship-Centered Communication. Formerly education lead for The Academy of Communication in Healthcare, she is an internationally recognized expert in relationship-centered communication and patient experience. Dr. Cooley advises healthcare systems and academic institutions on integrating humanistic care with emerging technologies. A frequent keynote speaker and educator, she holds a PhD in Health Communication and is dedicated to advancing patient, family, and clinician outcomes through evidence-based communication and relationship practices.

Ujjwal Ratan is the leader for AI/ML and Data Science team in the AWS Healthcare and Life Science business unit and is also a Principal AI/ML Solutions Architect. Over the years, Ujjwal has been a thought leader in the healthcare and life sciences industry, helping multiple Global Fortune 500 organizations achieve their innovation goals by adopting machine learning. His work involving the analysis of medical imaging, unstructured clinical text and genomics has helped AWS build products and services that provide highly personalized and precisely targeted diagnostics and therapeutics. Ujjwal's work has also been featured in multiple global conferences, peer-reviewed publications or technical and scientific blogs.

Shane Creech is Vice President of Information Technology at Ob Hospitalist Group, where he leads enterprise technology strategy and digital transformation for an organization that partners with hospitals across 39 states to deliver 24/7 obstetric emergency care. He focuses on pragmatic, outcomes driven deployments of clinical systems, interoperability, and AI readiness to improve maternal health, clinical workflows, and operational resilience.

Ryan Mackey, MD, is a medical entrepreneur navigating the age of healthcare transformation, clinical technology, and operational complexity. With first-hand experience as a physician, medical director, innovation leader, and dynamic change agent, he brings a wealth of expertise to the healthcare industry. With 17 years of medical leadership in acute care, clinical, and practice settings, along with 14 years of experience in EHR, RCM, and informatics, Ryan has a deep understanding of the healthcare landscape. Additionally, he has 7 years of experience in health system management, where he has overseen care delivery, financial, and technology decisions. His clinical, operational, and technology expertise allows him to drive efficiency and create lasting impact across all aspects of healthcare systems, from acute and ambulatory care locations to corporate settings.

Tanay Tandon is the Founder and Chief Executive Officer of Commure, a $6 billion healthcare AI software platform powering daily workflows for over 250,000 clinicians across over 100 major health systems. Under his leadership, Commure has raised over $600 million from top-tier investors including General Catalyst, Sequoia Capital, Initialized, Y Combinator, and NVIDIA.

Tanay Tandon is the Founder and Chief Executive Officer of Commure, a $6 billion healthcare AI software platform powering daily workflows for over 250,000 clinicians across over 100 major health systems. Under his leadership, Commure has raised over $600 million from top-tier investors including General Catalyst, Sequoia Capital, Initialized, Y Combinator, and NVIDIA.

Dan Warner is President at Commure, where he leads the Enterprise business that
serves more than 150 healthcare organizations. His focus is on delivering an AI
platform that helps health systems improve revenue integrity, reduce clinical
burden, and modernize patient and operational workflows. Before Commure, Dan spent considerable time at Uber in its early days. He helped build the ridesharing business across Europe, the Middle East, and Africa, and later launched and led Uber Freight in Europe through its exit as General Manager. He also served as Vice President of Operations at brightwheel, the country’s largest early education software provider, where he helped scale the company’s operations and commercial foundations.
‍
Dan holds a master’s degree from the University of Portsmouth. He lives in
Wisconsin with his wife and two children.

Commure’s Chief Strategy Officer, Ian Shakil (pronounced like Shaquille, the basketball player) has an impressive track record of innovation in cutting edge domains such as wearables, smartglasses, global-scale digital health.

In 2012, he founded Augmedix with a mission to harness technology to improve the patient experience and allow doctors to focus on what matters most: patient care. Augmedix is the first-to-market category defining company in the Ambient AI space; the company was acquired by Commure in 2024.

Shakil holds a BSE in Biomedical Engineering from Duke University and an MBA from Stanford Graduate School of Business.

Before founding Augmedix in 2012, Shakil held a variety of roles at leading healthcare companies such as Edwards Lifesciences, MC10, Intuitive Surgical, and HealthTech Capital.

He currently resides in San Francisco’s SoMa District.

Dr. Jamie Colbert is Chief Medical Officer of Commure, a General Catalyst-backed health tech company that uses AI to transform care delivery and reduce friction for patients, providers and administrators. Prior to joining Commure he was CMO at Memora Health and Senior Medical Director for Delivery System Innovation and Analytics at Blue Cross Blue Shield of Massachusetts. Dr. Colbert maintains an active clinical practice at Mass General Brigham and is an adjunct professor at Harvard Medical School.

Max Kruger is Head of Forward Deployed Engineering at Commure (joined through its combination with Athelas), where he leads high‑impact deployments, special projects, and strategic partnerships with leading EHR platforms and health systems, including collaborations with Epic, MEDITECH, and many of the partners featured at Commure Nexus. He helped scale key product lines across Ambient AI and RCM before building the forward‑deployed function that translates clinical needs into deliverables at speed. Previously, Max held roles at Athelas, Nike, and helped scale Booker Vineyard to a successful acquisition by Constellation Brands. He studied biomedical engineering at Cal Poly and grew up in Lake Oswego, Oregon.